US Sales of Apple Watch Series 9 and Ultra 2 Are Ceasing: The Root Cause
That’s certainly an update worthy of the first page! I can provide you with some information if you’re wondering why sales of these well-liked Apple Watch models have been suspended in the US.
The Principal Offender: A Patent Conflict
The story revolves around a patent infringement lawsuit that Apple was sued by Masimo, a medical technology business, for. According to Masimo, Apple’s blood oxygen monitoring technology in the Ultra 2 and Series 9 watches violates its own patents.
The Present Situation:
- U.S. International Trade Commission (ITC) Decision: In October 2023, the ITC issued an order for Apple to cease importing the watch models that are infringing, ruling in favor of Masimo.
- Presidential Review: After Apple filed an appeal against the ITC decision, a presidential review period was established, which will run until December 25, 2023.
- Apple’s Preventive Steps: Apple intentionally stopped selling the Series 9 and Ultra 2 in the US in case the prospective import restriction was upheld:
- On December 21, 2023, online sales came to an end.
- December 24, 2023, will mark the end of retail store sales.
What Comes Next?
- Presidential Review Outcome: The President’s choice of the ITC ruling will determine the current state of uncertainty. The import prohibition on the timepieces will go into effect if the decision is upheld.
- Apple’s Options: In the event that the President makes a different choice, Apple is probably going to look into legal options in order to defend its blood oxygen technology and possibly start selling the impacted models again.
Important lessons learned:
- A patent battle and possible import ban have prompted a temporary halt to US sales.
- Customers may not be able to buy these Apple Watch models until the legal dispute is settled.
- When the presidential review draws to a close, keep checking back for more information.
Please ask if you’d like more information about any particular facet of this circumstance!